JPH02245198A - Measurement of superoxide dismutase and reagent for measuring - Google Patents
Measurement of superoxide dismutase and reagent for measuringInfo
- Publication number
- JPH02245198A JPH02245198A JP6715989A JP6715989A JPH02245198A JP H02245198 A JPH02245198 A JP H02245198A JP 6715989 A JP6715989 A JP 6715989A JP 6715989 A JP6715989 A JP 6715989A JP H02245198 A JPH02245198 A JP H02245198A
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- xanthine
- measuring
- superoxide dismutase
- sod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000019197 Superoxide Dismutase Human genes 0.000 title claims abstract description 12
- 108010012715 Superoxide dismutase Proteins 0.000 title claims abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 45
- 238000005259 measurement Methods 0.000 title description 17
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 42
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims abstract description 30
- 108010093894 Xanthine oxidase Proteins 0.000 claims abstract description 26
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims abstract description 20
- 102100033220 Xanthine oxidase Human genes 0.000 claims abstract description 18
- 229940075420 xanthine Drugs 0.000 claims abstract description 15
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 9
- 239000000852 hydrogen donor Substances 0.000 claims abstract description 9
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 9
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 claims abstract description 4
- 239000000758 substrate Substances 0.000 claims abstract description 4
- 230000000694 effects Effects 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 150000002989 phenols Chemical class 0.000 claims description 5
- 238000006395 oxidase reaction Methods 0.000 claims description 3
- -1 phenol compound Chemical class 0.000 abstract description 20
- 238000002835 absorbance Methods 0.000 abstract description 13
- 238000012360 testing method Methods 0.000 abstract description 12
- 102000004190 Enzymes Human genes 0.000 abstract description 5
- 108090000790 Enzymes Proteins 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 8
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 8
- 229960004025 sodium salicylate Drugs 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 5
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 5
- 102000018832 Cytochromes Human genes 0.000 description 4
- 108010052832 Cytochromes Proteins 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 238000007323 disproportionation reaction Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 238000012802 pre-warming Methods 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- VRVSEBYMCSYYMF-UHFFFAOYSA-N (n,3-dimethylanilino)methanol Chemical compound OCN(C)C1=CC=CC(C)=C1 VRVSEBYMCSYYMF-UHFFFAOYSA-N 0.000 description 1
- AGRSZBOCZMNJIN-UHFFFAOYSA-N 1-[n-(2-hydroxypropyl)-3-methylanilino]propan-2-ol Chemical compound CC(O)CN(CC(C)O)C1=CC=CC(C)=C1 AGRSZBOCZMNJIN-UHFFFAOYSA-N 0.000 description 1
- PKHSCVWOHDRGOH-UHFFFAOYSA-N 2-(3-ethyl-n-methylanilino)ethanol Chemical compound CCC1=CC=CC(N(C)CCO)=C1 PKHSCVWOHDRGOH-UHFFFAOYSA-N 0.000 description 1
- WKTJWQHMWBDMAB-UHFFFAOYSA-N 2-(n,3-diethylanilino)ethanol Chemical compound OCCN(CC)C1=CC=CC(CC)=C1 WKTJWQHMWBDMAB-UHFFFAOYSA-N 0.000 description 1
- RWHHVRRGOAJMNV-UHFFFAOYSA-N 2-(n,3-dimethylanilino)ethanol Chemical compound OCCN(C)C1=CC=CC(C)=C1 RWHHVRRGOAJMNV-UHFFFAOYSA-N 0.000 description 1
- KRNUKKZDGDAWBF-UHFFFAOYSA-N 2-(n-ethyl-n-m-toluidino)ethanol Chemical compound OCCN(CC)C1=CC=CC(C)=C1 KRNUKKZDGDAWBF-UHFFFAOYSA-N 0.000 description 1
- HYVGFUIWHXLVNV-UHFFFAOYSA-N 2-(n-ethylanilino)ethanol Chemical compound OCCN(CC)C1=CC=CC=C1 HYVGFUIWHXLVNV-UHFFFAOYSA-N 0.000 description 1
- SCIPJHMVMRMZOW-UHFFFAOYSA-N 2-(n-methyl-3-propylanilino)ethanol Chemical compound CCCC1=CC=CC(N(C)CCO)=C1 SCIPJHMVMRMZOW-UHFFFAOYSA-N 0.000 description 1
- VIIZJXNVVJKISZ-UHFFFAOYSA-N 2-(n-methylanilino)ethanol Chemical compound OCCN(C)C1=CC=CC=C1 VIIZJXNVVJKISZ-UHFFFAOYSA-N 0.000 description 1
- VMNDRLYLEVCGAG-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-3-methylanilino]ethanol Chemical compound CC1=CC=CC(N(CCO)CCO)=C1 VMNDRLYLEVCGAG-UHFFFAOYSA-N 0.000 description 1
- GIVVIAIOYXFANR-UHFFFAOYSA-N 3-(n,3-dimethylanilino)propan-1-ol Chemical compound OCCCN(C)C1=CC=CC(C)=C1 GIVVIAIOYXFANR-UHFFFAOYSA-N 0.000 description 1
- NZAVBNVWEPQSBL-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethoxyanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC(OC)=CC(OC)=C1 NZAVBNVWEPQSBL-UHFFFAOYSA-N 0.000 description 1
- CDGBQMHYFARRCC-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC(C)=CC(C)=C1 CDGBQMHYFARRCC-UHFFFAOYSA-N 0.000 description 1
- NPROGRQJOGOVDS-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethylanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC(C)=CC(C)=C1 NPROGRQJOGOVDS-UHFFFAOYSA-N 0.000 description 1
- ZTQGWROHRVYSPW-UHFFFAOYSA-N 3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 ZTQGWROHRVYSPW-UHFFFAOYSA-N 0.000 description 1
- OSLLNBXAVOQCHO-UHFFFAOYSA-N 3-(n-ethyl-3-methylanilino)propan-1-ol Chemical compound OCCCN(CC)C1=CC=CC(C)=C1 OSLLNBXAVOQCHO-UHFFFAOYSA-N 0.000 description 1
- LHZMSRLULDAWLM-UHFFFAOYSA-N 3-(n-ethylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC=C1 LHZMSRLULDAWLM-UHFFFAOYSA-N 0.000 description 1
- POAYVWFHRAXGFC-UHFFFAOYSA-N 3-ethyl-n,n-dimethylaniline Chemical compound CCC1=CC=CC(N(C)C)=C1 POAYVWFHRAXGFC-UHFFFAOYSA-N 0.000 description 1
- DUFIFXVQSKZLTB-UHFFFAOYSA-N 3-methyl-n,n-dipropylaniline Chemical compound CCCN(CCC)C1=CC=CC(C)=C1 DUFIFXVQSKZLTB-UHFFFAOYSA-N 0.000 description 1
- GZFGOTFRPZRKDS-UHFFFAOYSA-N 4-bromophenol Chemical compound OC1=CC=C(Br)C=C1 GZFGOTFRPZRKDS-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical compound [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 101710171243 Peroxidase 10 Proteins 0.000 description 1
- 101710171315 Peroxidase 30 Proteins 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- 229940072082 magnesium salicylate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- QXVXYDKXAMNIOE-UHFFFAOYSA-N n,n,3-triethylaniline Chemical compound CCN(CC)C1=CC=CC(CC)=C1 QXVXYDKXAMNIOE-UHFFFAOYSA-N 0.000 description 1
- CWOMTHDOJCARBY-UHFFFAOYSA-N n,n,3-trimethylaniline Chemical compound CN(C)C1=CC=CC(C)=C1 CWOMTHDOJCARBY-UHFFFAOYSA-N 0.000 description 1
- OVSARSKQWCLSJT-UHFFFAOYSA-N n,n-di(propan-2-yl)aniline Chemical compound CC(C)N(C(C)C)C1=CC=CC=C1 OVSARSKQWCLSJT-UHFFFAOYSA-N 0.000 description 1
- CIPVVROJHKLHJI-UHFFFAOYSA-N n,n-diethyl-3-methylaniline Chemical compound CCN(CC)C1=CC=CC(C)=C1 CIPVVROJHKLHJI-UHFFFAOYSA-N 0.000 description 1
- KSWZVOMUTZUCQW-UHFFFAOYSA-N n,n-dimethyl-3-propylaniline Chemical compound CCCC1=CC=CC(N(C)C)=C1 KSWZVOMUTZUCQW-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- FRMWBRPWYBNAFB-UHFFFAOYSA-M potassium salicylate Chemical compound [K+].OC1=CC=CC=C1C([O-])=O FRMWBRPWYBNAFB-UHFFFAOYSA-M 0.000 description 1
- 229960003629 potassium salicylate Drugs 0.000 description 1
- CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 229950000975 salicylanilide Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- MOODSJOROWROTO-UHFFFAOYSA-N salicylsulfuric acid Chemical compound OC(=O)C1=CC=CC=C1OS(O)(=O)=O MOODSJOROWROTO-UHFFFAOYSA-N 0.000 description 1
- 229950001102 salicylsulfuric acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は体液、たとえば血清等に含まれるスーパーオキ
シダーゼ(以下SODと略す)の活性測定法とそれに用
いる試薬に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a method for measuring the activity of superoxidase (hereinafter abbreviated as SOD) contained in body fluids, such as serum, and a reagent used therein.
(従来の技術)
生体内で生成される活性酸素の1種で訴るスーパーオキ
サイドアニオン(以下0□−)は炎症、老化、癌の原因
となることが近年明らかにされてきている。一方、生体
内で02−を不均化させる反応に関するSODの存在も
明らかにされ、この酵素が生体を酸素前から守っている
と考えられてきている。このような考えから血清中のS
OD活性の簡便な測定法の開発は、臨床病理学的にも臨
床検査の観点からも待ち望まれている。(Prior Art) In recent years, it has been revealed that superoxide anion (hereinafter referred to as 0□-), which is a type of active oxygen produced in living bodies, causes inflammation, aging, and cancer. On the other hand, the existence of SOD, which is involved in the reaction that disproportionates 02- in the body, has also been revealed, and it is believed that this enzyme protects the body from oxygen exposure. Based on this idea, S in serum
The development of a simple method for measuring OD activity is eagerly awaited from the viewpoints of clinicopathology and clinical testing.
従来のSOD活性測定法としては、ニトロブルーテトラ
ゾリウム法、チトクロームC法等がある。これらの方法
は、0゜−発生系にキサンチン、キサンチンオキシダー
ゼを用いており、SODにより0□−が過酸化水素に不
均化されることにょるニトロブルーテトラゾリウム、チ
トクロームCの還元型の減少を阻害率で表わしてSOD
の活性を求めている。Conventional methods for measuring SOD activity include the nitro blue tetrazolium method and the cytochrome C method. These methods use xanthine and xanthine oxidase in the 0°-generation system, and reduce the reduced forms of nitroblue tetrazolium and cytochrome C due to the dismutation of 0□- to hydrogen peroxide by SOD. SOD expressed as inhibition rate
I'm looking for activation.
以下、従来技術としてニトロブルー5テトラゾリウム法
について説明する。The nitroblue 5-tetrazolium method will be described below as a conventional technique.
キサンチンにキサンチンオキシダーゼが作用すると02
−が生成する[(I)式]。生成した02−は共存する
ニトロブルーテトラゾリウム(NET)を還元し、ジホ
ルマザンを形成する[■式コが、反応液中にスーパーオ
キサイドジスムターゼ(S。When xanthine oxidase acts on xanthine, 02
- is generated [Formula (I)]. The generated 02- reduces the coexisting nitroblue tetrazolium (NET) to form diformazane [Formula 2] contains superoxide dismutase (S) in the reaction solution.
D)が存在すると、02−の一部は過酸化水素と酸素に
不均化され[(3)式コ、ジホルマザンの形成が減少す
る。従って、02″とNBTとの反応に基づくジホルマ
ザン形式の減少の程度を阻害率として求めることにより
、検体中のSOD活性を測定す一方、チトクロームC法
についても、ニトロブルーテトラゾリウムがチトクロー
ムCに換わるだけで原理的には同じである。In the presence of D), a portion of 02- is disproportionated to hydrogen peroxide and oxygen [(3), reducing the formation of diformazan. Therefore, while the SOD activity in the sample can be measured by determining the degree of inhibition of the diformazan form based on the reaction between 02'' and NBT, the cytochrome C method also requires that nitroblue tetrazolium is replaced with cytochrome C. The principle is the same.
しかし、これらの方法は、試薬盲検が高く、測定精度が
悪い。直接SOD活性を測定しているのではない等の問
題点が指摘されていた。However, these methods require high reagent blinding and have poor measurement accuracy. Problems such as not directly measuring SOD activity were pointed out.
また、SODによりN O2−が過酸化水素に不均化さ
れることを利用して、過酸化水素を測定しようという試
みもなされているが、0゜−発生系に用いるキサンチン
−キサンチンオキシダーゼ系は、02−だけでなく、過
酸化水素もその反応系から生成されるため、試薬盲検が
高くなり、SODの活性測定の精度は非常に悪いもので
あった。There have also been attempts to measure hydrogen peroxide by utilizing the disproportionation of N O2- into hydrogen peroxide by SOD, but the xanthine-xanthine oxidase system used for the 0°-generation system is , 02- as well as hydrogen peroxide are generated from the reaction system, the reagent blindness is high and the accuracy of SOD activity measurement is very poor.
(発明が解決しようとする課題)
本発明の目的は、試薬盲検に対する検体吸光度の現象を
測定する従来SODの活性測定法の欠点である試薬盲検
の高さ、測定精度の悪さ、測定範囲の狭さを改善した新
規かつ精度の高い簡便なSoDの活性測定法およびその
試薬を提供することである。(Problems to be Solved by the Invention) The purpose of the present invention is to solve the drawbacks of the conventional SOD activity measurement method that measures the phenomenon of sample absorbance against reagent blinding, such as high reagent blinding, poor measurement accuracy, and measurement range. An object of the present invention is to provide a novel, highly accurate and simple method for measuring SoD activity that improves the narrowness of the method, and a reagent for the same.
(課題を解決するための手段)
すなわち本発明はキサンチン又はヒポキサンチンにキサ
ンチンオキシダーゼを反応させることにより生成するス
ーパーオキサイドアニオンを基質としてスーパーオキサ
イドジスムターゼを作用させ、生成する過酸化水素の量
を測定することにより、スーパーオキサイドジスムター
ゼの活性を測定する方法において、フェノール化合物の
存在下にキサンチンオキシダーゼの反応を行うことを特
徴とするスーパーオキサイドジスムターゼの測定法およ
びi)キサンチン又はヒポキサンチン、i)キサンチン
オキシダーゼ、ii)フェノール化合物、iv)水素供
与体およびV)ペルオキシダーゼを含有することを特徴
とするスーパーオキサイドジスムターゼ測定用試薬であ
る。(Means for Solving the Problems) That is, the present invention involves reacting xanthine or hypoxanthine with xanthine oxidase, causing superoxide dismutase to act using superoxide anion as a substrate, and measuring the amount of hydrogen peroxide produced. In the method for measuring the activity of superoxide dismutase, the method for measuring superoxide dismutase is characterized by carrying out a xanthine oxidase reaction in the presence of a phenolic compound, and i) xanthine or hypoxanthine, i) xanthine oxidase, A reagent for measuring superoxide dismutase characterized by containing ii) a phenol compound, iv) a hydrogen donor, and V) peroxidase.
本発明は0□−発生系にキサンチン又はヒポキサンチン
−キサンチンオキシダーゼ系を用いる際、フェノール化
合物を添加することによりキサンチン又はヒポキサンチ
ン−キサンチンオキシダーゼ系からの過酸化水素の生成
を防ぎ、また、SODによって過酸化水素に変換されな
い過剰な02−をペルオキシダーゼと水素供与との反応
で消去することを特徴とする新規なSODの活性測定法
ならびにその試薬である。The present invention prevents the production of hydrogen peroxide from the xanthine or hypoxanthine-xanthine oxidase system by adding a phenol compound when using a xanthine or hypoxanthine-xanthine oxidase system in the 0□-generating system, and also prevents the production of hydrogen peroxide from the xanthine or hypoxanthine-xanthine oxidase system by The present invention provides a novel method for measuring SOD activity and its reagent, which is characterized in that excess 02- that is not converted to hydrogen peroxide is eliminated by a reaction between peroxidase and hydrogen donor.
本発明では、SODの活性測定の試薬盲検は低くなり、
しかもSODの活性は生成される過酸化水素量を測定す
ることにより求められるようになった。In the present invention, reagent blinding for SOD activity measurement is reduced;
Furthermore, the activity of SOD can now be determined by measuring the amount of hydrogen peroxide produced.
本発明に用いるキサンチンオキシダーゼはヒポキサンチ
ン又はキサンチンに作用してスーパーオキサイドアニオ
ンを生成する酵素であれば特に制限はない。このような
酵素としては例えば牛乳、咄乳動物の肝から精製された
ものがある。The xanthine oxidase used in the present invention is not particularly limited as long as it is an enzyme that acts on hypoxanthine or xanthine to produce superoxide anions. Examples of such enzymes include those purified from milk and the liver of mammals.
本発明においてフェノール化合物とは、キサンチン又は
ヒポキサンチン−キサンチンオキシダーゼ系から過酸化
水素が生成されるのを妨げる物質であればいかなるもの
でも良いが、例えばサリチル酸およびその塩、およびそ
の誘導体がある。In the present invention, the phenol compound may be any substance as long as it prevents the production of hydrogen peroxide from the xanthine or hypoxanthine-xanthine oxidase system, and includes, for example, salicylic acid, salts thereof, and derivatives thereof.
サリチル酸の塩としてはサリチル酸ナトリウム、サリチ
ル酸カリウム、サリチル酸マグネシウ6一
ム等がある。サリチル酸の誘導体としてはサリチルアル
コール、サリチルアルデヒド、サリチルアミド、サリチ
ルアニリド、サリチル酸メチル、サリチルスルフリック
酸などがある。フェノール化合物の有効濃度としては特
に制限がないが、SODの活性測定を好適に行うために
は0.01%〜10%(w/v)が好ましい。Examples of salicylic acid salts include sodium salicylate, potassium salicylate, and magnesium salicylate. Derivatives of salicylic acid include salicyl alcohol, salicylaldehyde, salicylamide, salicylanilide, methyl salicylate, and salicyl sulfuric acid. The effective concentration of the phenol compound is not particularly limited, but is preferably 0.01% to 10% (w/v) in order to suitably measure SOD activity.
本発明において水素供与体としては、例えば4−アミノ
アンチピリンとフェノール系化合物または4−アミノア
ンチピリンとN、N−ジ置換アニリン系化合物、ベンゾ
チアゾリノンヒドラゾン系化合物とアニリン系化合物な
どがある。Examples of the hydrogen donor in the present invention include 4-aminoantipyrine and a phenol compound, 4-aminoantipyrine and an N,N-disubstituted aniline compound, and a benzothiazolinone hydrazone compound and an aniline compound.
フェノール系化合物の具体例としては、p−クロロフェ
ノール、p−ブロモフェノール、3,5−ジクロロフェ
ノールスルホン酸、3−ヒドロキシ−2,4,E3−ト
リヨード安息香酸等が挙げられる。Specific examples of phenolic compounds include p-chlorophenol, p-bromophenol, 3,5-dichlorophenolsulfonic acid, 3-hydroxy-2,4,E3-triiodobenzoic acid, and the like.
アニリン系化合物の具体例としては、N−メチル−N−
ヒドロキシメチル−3−メチルアニリン、N−エチル−
N−ヒドロキシエチル−3−メチルアニリン、N−エチ
ル−N−ヒドロキシエチル−3−エチルアニリン、N−
メチル−N−ヒドロキシエチル−3−メチルアニリン、
N−メチル−N−ヒドロキシプロピル−3−メチルアニ
リン、N−エチル−N−ヒドロキシプロピル−3−メチ
ルアニリン、N−メチル−N−ヒドロキシエチル−3−
エチルアニリン、N−プロピル−Nヒドロキシエチル−
3−チルアニリン、N−メチル−N−ヒドロキシエチル
−3−プロピルアニリン、N、N−ビス(β−ヒドロキ
シエチル)−3−メチルアニリン、N、N−ビス(β−
ヒドロキシプロピル)−3−メチルアニリン、N、N−
ジメチル−3−メチルアニリン、N、N−ジメチル−3
−エチルアニリン、N、N−ジメチル−3−プロピルア
ニリン、N、N−ジエチル−3−メチルアニリン、N、
N−ジエチル−3−エチルアニリン、N、N−ジプロピ
ル−3−メチルアニリン、N−エチル−N−(β−メタ
ンスルホンアミドエチル)−m−)ルイジン、N−エチ
ル−N−(β−アセトアミドエチル)−3−メチルアニ
リン、N、N−ジメチルアニリン、N、N−ジエチルア
ニリン、N、N−ジイソプロピルアニリン、N−メチル
−N−ヒドロキシエチルアニリン、N−エチル−N−ヒ
ドロキシエチルアニリン、N−エチルーN−スルホプロ
ピル−m−)ルイジン、N−エチル−N−(2−ヒドロ
キシ−3−スルホプロピル)−m−)ルイジン、N−エ
チル−N−(2−ビトロキシ−3−スルホプロピル)、
m−アニシジン、N−エチル−N−(2−ヒドロキシ−
3−スルホプロピル)アニリン、3,5−ジメトキシ−
N−エチル−N−(2−71イドロキシ−3−スルホプ
ロピル)アニリン、3,5−ジメチル−N−エチル−N
−(2−ヒドロキシ−3−スルホプロピル)アニリン、
N−エチル−N−スルホプロピル−m−アニリン、N−
エチル−N−スルホプロピル−3,5−ジメチルアニリ
ン、N−エチル−N−スルホプロピル−3,5−ジメト
キシアニリン等が挙げられる。Specific examples of aniline compounds include N-methyl-N-
Hydroxymethyl-3-methylaniline, N-ethyl-
N-hydroxyethyl-3-methylaniline, N-ethyl-N-hydroxyethyl-3-ethylaniline, N-
Methyl-N-hydroxyethyl-3-methylaniline,
N-methyl-N-hydroxypropyl-3-methylaniline, N-ethyl-N-hydroxypropyl-3-methylaniline, N-methyl-N-hydroxyethyl-3-
Ethylaniline, N-propyl-Nhydroxyethyl-
3-Thylaniline, N-methyl-N-hydroxyethyl-3-propylaniline, N,N-bis(β-hydroxyethyl)-3-methylaniline, N,N-bis(β-
hydroxypropyl)-3-methylaniline, N,N-
Dimethyl-3-methylaniline, N,N-dimethyl-3
-ethylaniline, N,N-dimethyl-3-propylaniline, N,N-diethyl-3-methylaniline, N,
N-diethyl-3-ethylaniline, N,N-dipropyl-3-methylaniline, N-ethyl-N-(β-methanesulfonamidoethyl)-m-)luidine, N-ethyl-N-(β-acetamide ethyl)-3-methylaniline, N,N-dimethylaniline, N,N-diethylaniline, N,N-diisopropylaniline, N-methyl-N-hydroxyethylaniline, N-ethyl-N-hydroxyethylaniline, N -ethyl-N-sulfopropyl-m-)luidine, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-)luidine, N-ethyl-N-(2-bitroxy-3-sulfopropyl) ,
m-anisidine, N-ethyl-N-(2-hydroxy-
3-sulfopropyl)aniline, 3,5-dimethoxy-
N-ethyl-N-(2-71 idroxy-3-sulfopropyl)aniline, 3,5-dimethyl-N-ethyl-N
-(2-hydroxy-3-sulfopropyl)aniline,
N-ethyl-N-sulfopropyl-m-aniline, N-
Examples include ethyl-N-sulfopropyl-3,5-dimethylaniline and N-ethyl-N-sulfopropyl-3,5-dimethoxyaniline.
アニリン系化合物およびフェノール系化合物の使用濃度
に関しては特に制限がないが、0.1〜20mM程度が
最適である。4−アミノアンチピリンの使用濃度は1〜
20mM程度が好ましい。There is no particular restriction on the concentration of the aniline compound and the phenol compound used, but approximately 0.1 to 20 mM is optimal. The concentration of 4-aminoantipyrine used is 1~
About 20mM is preferable.
本発明に使用するペルオキシダーゼの濃度は1単位/−
〜100単位/ifあれば、好適にSODの活性測定を
行うことができる。The concentration of peroxidase used in the present invention is 1 unit/-
If it is 100 units/if, SOD activity can be suitably measured.
本発明を好適に実施しようとするときは、緩衝液中で行
う事が必要である。本発明の試薬のpHは、5.0〜9
.0出有ればいくらでもよいが、好ましくは、6.0〜
9.0である。When the present invention is to be carried out suitably, it is necessary to carry out the work in a buffer solution. The pH of the reagent of the present invention is 5.0 to 9.
.. Any amount is acceptable as long as it is 0, but preferably 6.0~
It is 9.0.
本発明ではキサンチン又はヒポキサンチンにフェノール
化合物の存在下にキサンチンオキシダーゼの反応を行い
、生成する02−を基質としてSODを作用させ、生成
する過酸化水素の量を常法に従って測定する。過酸化水
素の測定法としては、例えばペルオキシダーゼおよび水
素供与体を使用して発色させ、吸光度測定を行う方法が
ある。過酸化水素を測定する試薬、例えばペルオキシダ
ーゼおよび水素供与体は、キサンチンオキシダーゼの反
応系にフェノール化合物とともに存在していることが好
ましい。In the present invention, xanthine or hypoxanthine is reacted with xanthine oxidase in the presence of a phenol compound, SOD is applied using the produced 02- as a substrate, and the amount of hydrogen peroxide produced is measured according to a conventional method. As a method for measuring hydrogen peroxide, for example, there is a method of developing color using peroxidase and a hydrogen donor and measuring absorbance. Reagents for measuring hydrogen peroxide, such as peroxidase and a hydrogen donor, are preferably present together with a phenol compound in the xanthine oxidase reaction system.
本発明のSOD測定用試薬はi)キサンチン又はヒポキ
サンチン、i)キサンチンオキシダーゼ、ii)フェノ
ール化合物、iv)水素供与体およびV)ペルオキシダ
ーゼを含有する。The reagent for measuring SOD of the present invention contains i) xanthine or hypoxanthine, i) xanthine oxidase, ii) a phenol compound, iv) a hydrogen donor, and V) peroxidase.
(実施例) 以下に実施例を挙げて、本発明の詳細な説明する。(Example) EXAMPLES The present invention will be described in detail below with reference to Examples.
実施例 1゜
フェノール化合物の効果
第一試薬
キサンチンオキシダーゼを0.1単位/−、ペルオキシ
ダーゼを10単位/m1.4−アミノアンチピリンを0
.5モル/ノ、N−エチル−N−(2−ヒドロキシ−3
−スルホプロピル)−m−トルイジンを1.0mモル/
11サリチル酸ナトリウムを0.05%(W/V)の濃
度になるように、50mMBS(グツド緩衝液)pH6
,3に溶解した。Example 1゜Effect of phenolic compound First reagent xanthine oxidase 0.1 unit/-, peroxidase 10 units/m1.4-aminoantipyrine 0
.. 5 mol/no, N-ethyl-N-(2-hydroxy-3
-sulfopropyl)-m-toluidine 1.0 mmol/
11 Sodium salicylate was added to 50mMBS (Gud buffer) pH 6 to a concentration of 0.05% (W/V).
, 3.
第二試薬
ヒポキサンチンを20μモル/ノの濃度になるように蒸
留水に溶解した。A second reagent, hypoxanthine, was dissolved in distilled water to a concentration of 20 μmol/no.
第三試薬 第一試薬からサリチル酸ナトリウムを除いた試薬。third reagent A reagent obtained by removing sodium salicylate from the first reagent.
操 作
第二試薬1.5−を試験管にとり、37°C水浴中で5
分間予備加温後、第一試薬1.511L1!を試験管に
加え混合し、混合後5分後の550nmの吸光度を測定
した。サリチル酸ナトリウムの効果を見るため、上記操
作を第一試薬を第三試薬に置き換えて、同様におこなっ
た。測定結果を第1図に示す。図中、縦軸は550nm
における吸光度、横軸は測定時間(分)を示す。■はフ
ェノール化合物を添加したもの、■はフェノール化合物
無添加のものである。サリチル酸ナトリウムを添加して
いる第一試薬と第二試薬とを混合し反応させても試薬盲
検の吸光度は、上昇しない。これに反して、サリチル酸
ナトリウムを添加していない第三試薬と第二試薬を混合
すると、ヒポキサンチンから過酸化水素が生成されるた
め試薬盲検が明らかに上昇した。Procedure Place the second reagent 1.5- in a test tube and incubate for 5 minutes in a 37°C water bath.
After prewarming for 1 minute, the first reagent is 1.511L1! were added to a test tube and mixed, and the absorbance at 550 nm was measured 5 minutes after mixing. In order to examine the effect of sodium salicylate, the above operation was repeated in the same manner, replacing the first reagent with the third reagent. The measurement results are shown in Figure 1. In the figure, the vertical axis is 550 nm
The absorbance at , the horizontal axis indicates the measurement time (minutes). ■: A phenol compound was added, and ■: a phenol compound was not added. Even if the first reagent to which sodium salicylate is added and the second reagent are mixed and reacted, the absorbance of the reagent blind test does not increase. On the contrary, when the third reagent to which no sodium salicylate was added was mixed with the second reagent, the reagent blindness clearly increased due to the formation of hydrogen peroxide from hypoxanthine.
以上のことから、サリチル酸ナトリウムにより、キサン
チンオキシダーゼの二電子伝達が阻害されていることが
分かる。From the above, it can be seen that sodium salicylate inhibits the two-electron transfer of xanthine oxidase.
実施例 2
SODの測定
実施例1の第一試薬と第二試薬を用いてSODの測定を
行った。Example 2 Measurement of SOD Using the first reagent and second reagent of Example 1, SOD was measured.
試 料
東洋紡績−社製SOD (牛血溝由来)を600単位/
dになるように蒸留水に溶解した。Sample Toyobo - 600 units of SOD (derived from bovine blood groove)
d in distilled water.
操 作
試料50μノを試験管にとり、37℃水浴中で5分間予
備加温後、第一試薬1.5献を試験管に加え、混合し、
続いて第二試薬1.5Jを加え混合した。第二試薬混合
後5分後の550 nmの吸光度を測定した。試薬盲検
は、試料の代わりに蒸留水を用いて、上記操作と同様に
行った。測定結果を第2図に示す。図中、縦軸は550
nmにおける吸光度、横軸は測定時間(分)を示す。■
は5OD600単位/+L1の試料を測定したもの、■
は蒸留水を試料にして測定したものである。試薬盲検と
試料(SOD 800単位/1L1)を測定したとき
との吸光度差は、明らかであり、SODにより生成され
た過酸化水素が測定されていることが分かる。Place 50μ of the operation sample in a test tube, prewarm it in a 37°C water bath for 5 minutes, add 1.5 parts of the first reagent to the test tube, mix,
Subsequently, 1.5 J of the second reagent was added and mixed. Absorbance at 550 nm was measured 5 minutes after mixing the second reagent. Reagent blind testing was performed in the same manner as above, using distilled water instead of the sample. The measurement results are shown in Figure 2. In the figure, the vertical axis is 550
Absorbance in nm, horizontal axis indicates measurement time (minutes). ■
is measured on a sample of 5OD600 units/+L1, ■
is measured using distilled water as a sample. The difference in absorbance between the reagent blind measurement and the measurement of the sample (SOD 800 units/1L1) is clear, indicating that hydrogen peroxide produced by SOD is being measured.
実施例 3゜
SODの活性測定
第一試薬
キサンチンオキシダーゼを0.4単位/+d、ペルオキ
シダーゼを30単位/−14−アミノアンチピリンを0
.5mモル/je、N−エチルN−(2−ヒドロキシ−
3−スルホプロピル)−m−トルイジンを1.0モル/
ノ、サリチル酸ナトリウムを2.0%(W / V )
の濃度になるように、50mトリス−HCノ緩衝液pH
8,0に溶解した。Example 3 SOD activity measurement First reagent xanthine oxidase 0.4 units/+d, peroxidase 30 units/-14-aminoantipyrine 0
.. 5 mmol/je, N-ethyl N-(2-hydroxy-
1.0 mol/3-sulfopropyl)-m-toluidine
Sodium salicylate 2.0% (W/V)
50 m Tris-HC buffer pH to a concentration of
It was dissolved at 8.0.
第二試薬
ヒポキサンチンを50μモル/lの濃度になるように蒸
留水に溶解した。A second reagent, hypoxanthine, was dissolved in distilled water to a concentration of 50 μmol/l.
試 料
東洋紡績M社製SOD (牛血清由来)を0゜20.4
0,60,100単位/−になるように蒸留水に溶解し
た。Sample SOD (derived from bovine serum) manufactured by Toyobo M Co., Ltd. at 0°20.4
It was dissolved in distilled water to a concentration of 0,60,100 units/-.
操 作
試料0.15m1を試験管にとり、37°C水浴中で5
分間予備加温後、第一試薬1.5.、Jを試験管に加え
混合し、続いて第二試薬1.5dを加え混合した。第二
試薬混合後、5分間の550nmの吸光度の上昇率(Δ
0D550/分)を測定した。試薬盲検は、試料の代わ
りに蒸留水を用いて、上記操作と同様に行った。測定結
果を第3図に示す。縦軸は550nmにおける1分間当
りの吸光度変化量、横軸はSODの濃度(単位/d)を
示す。Place 0.15ml of the operational sample in a test tube and incubate for 5 minutes in a 37°C water bath.
After prewarming for minutes, first reagent 1.5. , J were added to the test tube and mixed, and then 1.5 d of the second reagent was added and mixed. After mixing the second reagent, the rate of increase in absorbance at 550 nm (Δ
0D550/min) was measured. Reagent blind testing was performed in the same manner as above, using distilled water instead of the sample. The measurement results are shown in Figure 3. The vertical axis shows the amount of change in absorbance per minute at 550 nm, and the horizontal axis shows the concentration of SOD (unit/d).
試料の濃度が高くなるに従って、550nmの吸光度の
上昇率(Δ0D550/分)も高くなった。5OD10
0単位/+n1まで直線性が高く、また試薬盲検の55
0nmの吸光度の上昇率(Δ0D550/分)も非常に
低い。As the sample concentration increased, the rate of increase in absorbance at 550 nm (Δ0D550/min) also increased. 5OD10
High linearity up to 0 units/+n1, and reagent-blind 55
The rate of increase in absorbance at 0 nm (Δ0D550/min) is also very low.
以上のことから、本発明は実用性の高いSOD測定法で
あることが分かる。From the above, it can be seen that the present invention is a highly practical SOD measurement method.
(発明の効果)
本発明のSODの活性測定法およびその試薬によればフ
ェノール化合物の添加より、キサンチンオキシダーゼに
よる過酸化水素の生成を防ぎ、またペルオキシダーゼと
水素供与体により過剰な02−を消去するこきが可能と
なった。このことより、SODによって不均化された過
酸化水素だけが測定されることになり、試薬盲検が低い
、精度の高いSODの測定法及びその試薬を提供するこ
とが可能となった。(Effects of the Invention) According to the SOD activity measuring method and its reagent of the present invention, the addition of a phenol compound prevents the production of hydrogen peroxide by xanthine oxidase, and also eliminates excess 02- by peroxidase and a hydrogen donor. Koki became possible. As a result, only hydrogen peroxide disproportionated by SOD is measured, making it possible to provide a highly accurate SOD measurement method with low reagent blinding and its reagent.
第1図は、実施例1におけるフェノール化合物の効果を
示したグラフである。
第2図は、実施例2におけるSOD測定のグラフである
。
第3図は、実施例3におけるSOD測定のグラフである
。FIG. 1 is a graph showing the effect of the phenol compound in Example 1. FIG. 2 is a graph of SOD measurement in Example 2. FIG. 3 is a graph of SOD measurement in Example 3.
Claims (2)
シダーゼを反応させることにより生成するスーパーオキ
サイドアニオンを基質としてスーパーオキサイドジスム
ターゼを作用させ、生成する過酸化水素の量を測定する
ことにより、スーパーオキサイドジスムターゼの活性を
測定する方法において、フェノール化合物の存在下にキ
サンチンオキシダーゼの反応を行うことを特徴とするス
ーパーオキサイドジスムターゼの測定法。(1) The activity of superoxide dismutase is measured by acting on superoxide dismutase using the superoxide anion produced by reacting xanthine or hypoxanthine with xanthine oxidase as a substrate and measuring the amount of hydrogen peroxide produced. A method for measuring superoxide dismutase, which comprises carrying out a xanthine oxidase reaction in the presence of a phenolic compound.
チンオキシダーゼ、iii)フェノール化合物、iv)
水素供与体およびv)ペルオキシダーゼを含有すること
を特徴とするスーパーオキサイドジスムターゼ測定用試
薬。(2) i) xanthine or hyposanthin, ii) xanthine oxidase, iii) phenolic compound, iv)
A reagent for measuring superoxide dismutase, comprising a hydrogen donor and v) peroxidase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6715989A JP2805805B2 (en) | 1989-03-17 | 1989-03-17 | Method for measuring superoxide dismutase and reagent for measurement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6715989A JP2805805B2 (en) | 1989-03-17 | 1989-03-17 | Method for measuring superoxide dismutase and reagent for measurement |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02245198A true JPH02245198A (en) | 1990-09-28 |
JP2805805B2 JP2805805B2 (en) | 1998-09-30 |
Family
ID=13336837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6715989A Expired - Fee Related JP2805805B2 (en) | 1989-03-17 | 1989-03-17 | Method for measuring superoxide dismutase and reagent for measurement |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2805805B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110567947A (en) * | 2019-05-29 | 2019-12-13 | 北京泰德制药股份有限公司 | Kit for detecting activity of phosphatidized recombinant human superoxide dismutase |
CN114480563A (en) * | 2022-01-14 | 2022-05-13 | 广州达安基因股份有限公司 | Composition and kit for detecting adenosine deaminase activity |
-
1989
- 1989-03-17 JP JP6715989A patent/JP2805805B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110567947A (en) * | 2019-05-29 | 2019-12-13 | 北京泰德制药股份有限公司 | Kit for detecting activity of phosphatidized recombinant human superoxide dismutase |
CN110567947B (en) * | 2019-05-29 | 2024-05-03 | 北京泰德制药股份有限公司 | Kit for detecting activity of phosphatized recombinant human superoxide dismutase |
CN114480563A (en) * | 2022-01-14 | 2022-05-13 | 广州达安基因股份有限公司 | Composition and kit for detecting adenosine deaminase activity |
Also Published As
Publication number | Publication date |
---|---|
JP2805805B2 (en) | 1998-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0823943B1 (en) | Determination of glycated proteins | |
JPS63182000A (en) | Measurement of creatine or creatinine and reagent therefor | |
JP4639287B2 (en) | Stabilization method for enzymatic measurement reagents | |
EP0193204B1 (en) | Process for determining superoxide dismutase activity | |
JPH042240B2 (en) | ||
JPH0571239B2 (en) | ||
JPH02245198A (en) | Measurement of superoxide dismutase and reagent for measuring | |
Hynie et al. | Determination of phosphodiesterase I activity in human blood serum | |
JP3601648B2 (en) | Biological component measuring reagent and measuring method | |
JPH07155196A (en) | Measuring method of biological components | |
JP2922267B2 (en) | Component analysis method | |
JP4577863B2 (en) | Composition for measuring calcium ion and measuring method | |
JPS603480B2 (en) | Creatinine and creatine determination method | |
JPH04200396A (en) | High-sensitivity enzymatic determination of hydrogen peroxide and reagent therefor | |
JPS61173799A (en) | Method of determining activity of substrate or enzyme | |
JPH01112155A (en) | Method for determination of hydrogen peroxide and reagent for said determination | |
JP6047778B2 (en) | Method and reagent for measuring substance to be measured, and method for avoiding influence derived from bilirubin | |
JPS5880556A (en) | Chromogen for colorimetry of peroxide | |
JPH0313880B2 (en) | ||
JPS6030696A (en) | Method and reagent for determination of creatinine and creatine | |
JPS6342470A (en) | Method for measuring peroxidase or h2o2 | |
JPS63245696A (en) | Method for measuring ceruloplasmin activity | |
JP4517066B2 (en) | Enzyme activity measuring reagent containing a trace amount of azide and measuring method | |
CN116075594A (en) | Ways to Reduce Measurement Errors | |
JPH03119997A (en) | Method for measuring ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080724 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |